EVIDENCE LIBRARY
Metoprolol in a cocaine-bupropion case: a proposed benzodiazepine alternative was not a head-to-head trial
A toxicity report described improvement after beta-blockade but cannot establish comparative superiority over benzodiazepines.
A toxicity report described improvement after beta-blockade but cannot establish comparative superiority over benzodiazepines.
The reported response
A 25-year-old woman presented with agitation, tachycardia, and marked QT-interval prolongation after cocaine and bupropion exposure. The report described improvement after intravenous metoprolol. The authors discussed this approach in contrast with benzodiazepine-based management.
That discussion is clinical interpretation of one course, not random allocation to metoprolol versus a benzodiazepine. The observed response cannot establish which approach would have produced the better overall outcome in the same patient.
A successful case is not a class-wide safety comparison
Combined stimulant toxicity, evolving drug concentrations, and subsequent care complicate attribution. A case report cannot quantify the relative risks of respiratory depression, sedation, arrhythmia, or recurrent seizures across treatment strategies.
For evidentiary use, identify what was actually administered and when, then distinguish that observation from the authors’ proposal about alternatives. The paper is useful for understanding a treatment hypothesis in mixed poisoning. It does not establish that benzodiazepines are generally ineffective or that one beta-blocker is universally preferable.
Source paper
Original analysis of the supplied journal article, identified as PMC6453686.